We are a Swiss microbiome biotherapeutics company with two key platforms:
ApyraVax with the lead indication of Clostridioides difficile infection
ApyraMed with lead indications as Cancer Immunotherapy Enhancer and Dysbiosis

Location

Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2018

  • Number of employees in Switzerland

    1-9

Key business